Since most other markers have not been reported for more detailed evaluation of the clinical performance of detecting different stages of CRC, the sensitivity of methylated SDC2 for all stage CRC could be compared to those of methylated C9orf50 and KCNQ5 [41], which were very similar among all three methylation markers. The gene discussed is C9orf50; the disease is colorectal carcinoma.